Inflammatory bowel diseases (IBD) are chronic conditions characterised by inflammation of the gastrointestinal tract, which leads to a range of symptoms such as abdominal pain, diarrhoea, tiredness and weight loss. Diagnosing IBD can be challenging, because the symptoms are similar to those of other gastrointestinal disorders. However, advances in medical research have led to the discovery of valuable biomarkers, such as calprotectin, which plays an important role in detecting and monitoring IBD.
What is calprotectin?
Calprotectin is a protein released by activated neutrophils, a type of white blood cell, in response to inflammation. When there is inflammation in the gastrointestinal tract, the level of calprotectin in the stool rises significantly. Measuring the level of calprotectin in the stool gives valuable information about the presence and degree of inflammation in the lining of the bowel, which makes it a reliable biomarker for IBD.
The role of calprotectin in diagnosing IBD
One of the major challenges in diagnosing IBD is telling these diseases apart from other gastrointestinal disorders with similar symptoms. Traditional diagnostic methods that can make this distinction, such as endoscopy and colonoscopy, are invasive medical procedures that require preparation beforehand. However, these methods are not necessary for every patient, and it is precisely the calprotectin test, as a non-invasive test, that helps doctors judge which patients really need other diagnostic methods.
When a patient has symptoms that suggest IBD, the doctor may request a stool calprotectin test. Raised calprotectin levels indicate inflammation in the gastrointestinal tract, which may point to IBD, particularly Crohn’s disease and ulcerative colitis.
Benefits of calprotectin testing
- Non-invasive test – the calprotectin test needs a stool sample, which makes it a non-invasive and acceptable diagnostic option for patients, including children.
- Early detection – calprotectin levels rise early in the course of inflammation, which allows IBD to be detected in its early stages.
- Monitoring disease activity – for patients already diagnosed with IBD, monitoring calprotectin levels over time can help to assess disease activity and the response to treatment. A fall in calprotectin levels indicates reduced inflammation, while raised values indicate active disease.
- Treatment decisions – calprotectin test results can help the doctor decide on further diagnostic procedures and treatment options.
How calprotectin is measured
For the calprotectin test, a small stool sample needs to be collected. Patients can collect the sample at home and then send it to the laboratory for analysis. The test can be done during routine check-ups, when the patient has no symptoms, or when symptoms appear.
The calprotectin test has been a major advance in the diagnosis and treatment of inflammatory bowel diseases. As a non-invasive and cost-effective biomarker, it offers many benefits to patients and healthcare professionals alike. Detecting and monitoring inflammation in the gastrointestinal tract with calprotectin helps in the early diagnosis of IBD, makes treatment decisions easier and helps to assess disease activity during treatment. If you have symptoms that suggest IBD, ask your doctor whether the calprotectin test would be the right choice for you. Early detection of the disease and timely treatment significantly improve the quality of IBD care.